IP Library Granted Patent US 11,427,589
Granted Patent B2
US 11,427,589 · App. 16/781,206 · Granted Aug 30, 2022

Compositions comprising folic acid derivatives, their preparations and methods of use

Inventors: Gerald S. Jones, Jr. (Norwood, MA); Joseph P. St. Laurent (Lakeville, MA); Scott A. Goodrich (Stoughton, MA)
Assignee: JSB PHARMA DEVELOPMENT, LLC
C07D475/04A61K31/519C07D487/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,427,589
App. No.
16/781,206
Granted
Aug 30, 2022
Kind
B2
Abstract

Described herein are methods for making folic acid derivatives, intermediates, pharmaceutical compositions and uses thereof.

Claims (15)

1. A solid pharmaceutical composition comprising a compound of Formula (V):

wherein

R 1 and R 2 are each independently selected from H, OH, NH 2 , C 1-6 alkyl or aryl;

R 3 is H, C 1-6 alkyl or aryl; and

Y is halo.

2. The solid pharmaceutical composition of claim 1 , wherein R 1 is NH 2 .

3. The solid pharmaceutical composition of claim 1 , wherein R 2 is OH.

4. The solid pharmaceutical composition of claim 1 , wherein R 3 is H.

5. The solid pharmaceutical composition of claim 1 , wherein Y is chloro.

6. The solid pharmaceutical composition of claim 1 , wherein the solid pharmaceutical composition is a tablet.

7. The solid pharmaceutical composition of claim 1 , wherein the solid pharmaceutical composition is a dragee.

8. The solid pharmaceutical composition of claim 1 , wherein the solid pharmaceutical composition is a capsule.

9. The solid pharmaceutical composition of claim 1 , wherein the solid pharmaceutical composition is a pill.

10. The solid pharmaceutical composition of claim 1 , wherein the solid pharmaceutical composition is a granule.

11. The solid pharmaceutical composition of claim 1 , wherein the solid pharmaceutical composition is formulated for oral administration.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2022
From: JONES, GERALD S., JR.; ST. LAURENT, JOSEPH P.; GOODRICH, SCOTT A.
To: CHEMIC LABORATORIES, INC.
Reel/Frame 059033/0190 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 17, 2022
From: CHEMIC LABORATORIES, LLC
To: JSB PHARMA DEVELOPMENT, LLC
Reel/Frame 059035/0566 →
CHANGE OF NAME Recorded Feb 17, 2022
From: CHEMIC LABORATORIES, INC.
To: CHEMIC LABORATORIES, LLC
Reel/Frame 059254/0680 →
Continuity (6)
Continuation 16288812 · Feb 28, 2019
Division 15912070 · Mar 5, 2018
Continuation 15173164 · Jun 3, 2016
Continuation 14417504
Provisional Application 61676651 · Jul 27, 2012
Related Publication 20210002281A1 · Jan 7, 2021